Polyrizon Ltd.

PLRZ | NASDAQ

Price Alert Chart Builder DCF Calculator

$10.90

-$0.09 (-0.82%)

At close: Sep 21, 2026, 4:00 PM ET

$10.89

-$0.01 (-0.08%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.82%

(1D)

Rating

Updated: Aug 12, 2026

11.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $12.21M

1D Range

10.64 10.90

52W Range

2.88 18.20

Valuation (TTM)

PE -0.28

PB 0.58

EV/EBITDA 0.01

Valuation (NTM)

Forward PE N/A

Forward PEG -0.01

Price Target N/A

Cash Flow

FCF Yield -28.9%

SBC Adj. FCF Yield -28.9%

SBC Impact N/A

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -42.7% | -50.8%

FCF 3Y | 5Y -96.4% | -51.2%

Returns

ROA -15.6%

ROE -16.9%

ROIC -29.8%

Financial Health

Net Cash

$12.27M

Current Ratio 29.03

Interest Coverage -1.34

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier w...

Sector Healthcare

Industry Biotechnology

Employees 6

IPO Date Oct 28, 2024

Website www.polyrizon-biotech.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.